What is Male Infertility Treatment?
Male infertility treatment is a common issue among men. Conception is a difficult process with numerous challenges. Fortunately, having infertility issues does not automatically rule out the possibility of having a child with your partner. There are treatments and procedures that can improve your chances of getting pregnant. Infertility is a problem with your reproductive system that prevents you from becoming pregnant. If a male and a female have had unprotected sex for more than a year and the female does not become pregnant, do not worry if you, she, or both of you have male infertility. Infertility is a common problem, affecting more than five million couples in the United States. One in every six couples attempting to conceive suffers from infertility. A male factor is a major or contributing cause in at least half of all cases of infertility. This means that approximately 10% of all males in the United States who are attempting to conceive are infertile.
|Unit||Value (USD Million)|
|Key Companies Profiled||Bayer Healthcare (Germany), Andrology Solutions (United Kingdom), Aytu BioScience, Inc. (United States), Cadila Healthcare Ltd. (India), Halotech DNA SL (Spain), EMD Sereno, Inc. (United States), SCSA Diagnostics, Inc. (United States), Intas Pharmaceuticals Ltd. (India), The Cooper Companies Inc. (United States) and Vitrolife AB (Sweden)|
The study covers a detailed analysis segmented by key business segments i.e. by type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay and Others) , by application (Hospitals, Clinics and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Male Infertility Treatment market throughout the predicted period.
The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Male Infertility Treatment market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, some of them are Bayer Healthcare (Germany), Andrology Solutions (United Kingdom), Aytu BioScience, Inc. (United States), Cadila Healthcare Ltd. (India), Halotech DNA SL (Spain), EMD Sereno, Inc. (United States), SCSA Diagnostics, Inc. (United States), Intas Pharmaceuticals Ltd. (India), The Cooper Companies Inc. (United States) and Vitrolife AB (Sweden).
On 5th August 2021, Bayer AG announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a biopharmaceutical company based in the United States that uses novel discovery technologies to unlock high-value, previously unreachable targets with precision therapeutics. The Vividion platform is capable of producing a wide range of small molecule therapies across indications, with an initial focus on oncology and immunology targets. Vividion's lead programmes include multiple precision oncology and precision immunology targets, as well as ongoing efforts on a transcription factor NRF2 antagonist for the potential treatment of NRF2 mutant cancers and NRF2 activators for various inflammatory diseases such as irritable bowel disease, among other pre-clinical programmes.
The Indian Council of Medical Research (ICMR) and the National Academy of Medical Sciences (NAMS) have issued National Guidelines for Accreditation, Supervision, and Regulation of ART Clinics in India to regulate and supervise ART clinics. These guidelines were developed following extensive discussion and debate among experts, ART practitioners, and the general public. I have great pleasure in presenting these guidelines, which I believe will be very useful in regulating and supervising the operation of ART Clinics and will assist ART Clinics in providing safe and ethical services to infertile couples in need. I would also like to express our gratitude to the ICMR and NAMS experts who worked tirelessly to develop these guidelines.
This male infertility treatment includes a detailed company profile, product offerings, production graphs, and revenue generated by each company. It also highlights each manufacturer's pricing trends, as well as their respective gross margins and market share during the forecast period. Due to the presence of multiple vendors, the male infertility treatment market is fragmented. Furthermore, advances in male infertility treatment have given women the option of having children later in life, leading to market growth.
Increasing Number of Sperm Donors at Sperm Banks and Growing Awareness through Online Advertisement for Infertility Services
Market Growth Drivers:
Rising Number of Fertility Clinics in Developing Countries and Technological Advancements in Male Infertility Treatment Devices
The High Cost of Procedures
Stringent Government Regulations and Lack of Medical Infrastructure in Underdeveloped Countries
Growth in Healthcare Infrastructure in Emerging Markets and Demand for Infertility Treatment Options by Same-Sex Couples
Key highlights of the Global Male Infertility Treatment market Study:
CAGR of the market during the forecast period 2022-2028
In-depth information on growth factors that will accelerate the Male Infertility Treatment market in next few years.
Detailed Insights on futuristic trends and changing consumer behavior
Forecast of the Global Male Infertility Treatment market size and its contribution to the parent market by type, application and by country.
A broad view of customer demand
Uncover markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Male Infertility Treatment Players
Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
A tipping point in globalization
A major slowdown in Western economies
Significant shifts in technology and cost structure
The challenges of regulatory compliance
New forms of competition developing
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Male Infertility Treatment market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Male Infertility Treatment market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Male Infertility Treatment Device Manufacturers, Medical Device Suppliers and Distributors, Healthcare Service Providers, Research Laboratories, Government Bodies, End-Users and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.